Member Info for DD77

https://twitter.com/xerostech/status/1466016054463893517?s=21

I’ve topped up again today, average down to £3.21. Still think this will turn at some point and the herd will arrive. Remember the company had an oversubscribed placing in March at £2.40.

XSG just tweeted that they’ve got some exciting news coming later today…….

The Bill that MP Costa is proposing is getting heard in the House of Commons today
https://twitter.com/albertocostamp/status/1465612070016143372?s=21

Interim results are never very interesting other than cash burn.................be interested to listen to the Investor Meet this afternoon as that will likely be more revealing about what is going on behind the scenes and forthcoming developments which will drive the SP

How many warrants left now then?

Thanks Greg. I suppose the elephant in the room though is that their PCR covid test was CE marked back around May 2020 but they subsequently said that individual governments within the EU still carried out their own tests regardless of CE mark, which was a contributory factor to our lack of sales. Will it be the same this time around?

Not sure Surfbum, I did wonder that............only thing I can think of is it being related to the fact they said they've self-certified it?

.............

just deezerts - I think it's unlikely we will receive that information in December. The board doesn't operate like that. We will be getting a trading update in January so I would expect clarification then.

I agree it would be preferable to receive clarification/reassurance before then but think it's unlikely

ODX and AVCT aren’t

Is that some kind of p!ss take? Promoting his book?...............FFS. Makes your blood boil

I remain confident but the continued decline in SP and selling shows no signs of abating. It could really do with some news from the board

What are you basing the 60-70p target on?

Dicerna were bought out for $3.3bn. To get the equivalent here, the SP would 10 bag from here, so looking at £4.70 a share. Clearly there a more differences between the businesses than that, but that shows the potential

Gixer - bluecap approval is key to unlocking value here. If this fails any of the remaining 3 studies, it will significantly depress future outlook. DSM can already market in those countries today and we're not gaining traction

This is on the rise today...........anyone know why?

I agree, they need to focus on reducing debt further though

Tests/studies that By-Health are undertaking.........correction it appears it's 3 outstanding, not 4

That's assuming it passes the remaining 4 tests. There could be further delays or they could fail them - there's still risk here

RENE just can't hold any gains, why is that?

Draft - thanks for that link, really interesting insight. I bought in here about 6 months ago, predominantly for the H2 play, as I know about developments in the sector. My faith wavered a bit when the SP dropped into the teens but this has reaffirmed it. There is lots going on with this company, and plenty of H2 developments behind the scenes. Interesting that Copus mentioned about potential strategic investors from their clients in the geo space...........I hadn't considered this but it makes perfect sense given oil companies are looking to transition to energy companies. And both Shell and BP are looking at getting involved in hydrogen. I'll be looking at adding more here. MCAP of £23m, tiny. I sold out of VLS on Friday, making a nice gain..............i'll be back there but feel it will drop back a bit in the coming months